On September 10, 2025, Clearside Biomedical, Inc. announced a 1-for-15 reverse stock split and reduced its authorized shares from 400 million to approximately 26.67 million, effective September 12, 2025. This will adjust the number of shares and prices for outstanding stock options and equity compensation without altering ownership percentages.